Corneal stromal collagen matrix (CSCM) (CSCM)

The corneal stromal collagen matrix is the primary structural component of the eye's cornea, accounting for approximately 90% of its thickness. It is composed of highly organized, parallel collagen fibrils, predominantly Type I and Type V, which are embedded in a proteoglycan-rich ground substance to maintain corneal transparency and refractive stability (Source: StatPearls, "Anatomy, Airway, Cornea"). In diseases like keratoconus and post-LASIK ectasia, the biomechanical integrity of this matrix is compromised, leading to progressive thinning, bulging, and visual distortion (Source: NIH, "Keratoconus"). Therapeutic interventions primarily focus on strengthening the matrix through corneal collagen cross-linking (CXL), a procedure that utilizes riboflavin and ultraviolet-A light to induce covalent bonds between collagen fibers (Source: American Academy of Ophthalmology). Beyond cross-linking, the matrix is a target for regenerative medicine, where biosynthetic scaffolds and tissue-engineered constructs are used to replace damaged or scarred stromal tissue (Source: Nature Communications, "Bioengineered corneal stroma"). Additionally, the matrix is susceptible to enzymatic degradation by matrix metalloproteinases, which can lead to corneal melting in inflammatory conditions (Source: PubMed, "Matrix metalloproteinases in corneal health and disease"). Understanding the matrix's remodeling processes is critical for treating corneal blindness and improving the outcomes of refractive surgeries.

Other names

Corneal stromaCorneal extracellular matrixCorneal collagen fibrilsStromal ECM

Photo-oxidative cross-linking to increase biomechanical stability; inhibition of matrix metalloproteinases to prevent degradation; structural replacement via biosynthetic scaffolds.